Insulet (PODD) Other financing activities (2010 - 2020)

Insulet (PODD) reported Other financing activities of $500000.0 for Q4 2020, up 153.42% quarter-over-quarter from -$936000.0 in Q4 2010.

Insulet (PODD) Other financing activities (2010 - 2020) Analysis & Trends

Insulet has reported Other financing activities for 2 years, with the latest figure at $500000.0 in Q4 2020.

For the quarter ending Q4 2020, Other financing activities changed N/A year-over-year to $500000.0; the trailing twelve-month figure through Sep 2022 stood at $500000.0 (up 214.68% YoY), and the FY2023 full-year result was -$300000.0, changed N/A from the prior year.
Other financing activities for Q4 2020 stood at $500000.0, up from -$936000.0 in the prior quarter.
The five-year high for Other financing activities was $500000.0 in Q4 2020, with the low at $500000.0 in Q4 2020.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Abbott Laboratories	154.42 Bn	147.76 Bn	6.27 Bn
2	Stryker	118.12 Bn	115.25 Bn	3.81 Bn
3	Medtronic	101.72 Bn	93.55 Bn	5.76 Bn
4	Boston Scientific	67.19 Bn	65.98 Bn	3.61 Bn
5	Edwards Lifesciences	50.69 Bn	47.02 Bn	1.29 Bn
6	Koninklijke Philips	29.38 Bn	26.07 Bn	2.07 Bn
7	Dexcom	28.09 Bn	26.97 Bn	750.30 Mn
8	GE HealthCare Technologies	28.08 Bn	26.02 Bn	1.98 Bn
9	Steris	19.80 Bn	19.37 Bn	697.10 Mn
10	Insulet	10.20 Bn	9.72 Bn	529.10 Mn

Download Data